Abstract Purpose of the investigation: Insulin receptor (IR) may play an essential role in the development of beta cell mass in the mouse pancreas. To further define the function of this signaling system in beta cell development, we have generated IR-deficient beta cell lines. Methods: Fetal pancreata were dissected from mice harboring a floxed allele of the insulin receptor (IRLoxP) and used to isolate islets. These islets were infected with a retrovirus to express SV40 large T antigen, a strategy for establishing beta cell lines (β-IRLoxP). Subsequently, these cells were infected with adenovirus encoding cre recombinase to delete insulin receptor (β-IR-/-). Results: Beta cells expressed insulin and Pdx-1 mRNA in response to glucose. In β-IRLoxP beta cells, p44/p42 MAPK and PI 3 kinase pathways, mTOR and p70S 6 K phosphorylation and β-cell proliferation were stimulated in response to insulin. Wortmannin or PD98059 had no effect on insulinmediated mTOR/p70S 6 K signaling and the corresponding mitogenic response. However,
Introduction
Type 2 diabetes mellitus (NIDDM) is a complex metabolic disease with environmental and genetic origins which affects over 5% of the population in Western societies. The pathogenesis of type 2 diabetes involves abnormalities in both peripheral insulin action and insulin secretion by pancreatic beta-cells (1) . Transgenic technology has yielded various animal models of type 2 diabetes and these have advanced significantly the analysis of insulin signaling molecules implicated in the regulation of glucose homeostasis (2) . Recently, conditional knockout mice have been generated to define the specific roles of the insulin receptor (IR) and the insulin like growth factor I (IGF-IR) in pancreatic beta cell development (3, 4) . Beta-cell specific insulin receptor deficiency (BIRKO mice) causes defective insulin secretion, which leads to progressive glucose intolerance and hyperglycemia. This diabetic phenotype reflects an impairment of acute insulin secretion in response to glucose in fed mice, which is characteristic of patients with type-II diabetes (3) . Total pancreas insulin content is severely reduced in adult BIRKO mice as compared with controls. Moreover, gene expression analysis has revealed a significant reduction of GLUT 2 and glucokinase in both diabetic and non-diabetic BIRKO mice. However, reductions of beta-cell mass, islet number and insulin secretion are more pronounced in diabetic than in non-diabetic mutant mice (5) . Taken together, these data implicate a direct role for the insulin receptor in the beta-cell growth and suggest that this receptor may also modulate the glucose sensing machinery required for normal insulin secretion.
Interestingly, the beta-cell specific deletion of the IGF-IR creates a phenotype similar to BIRKO mice. These transgenic animals display a defect in glucose-stimulated insulin secretion due to reduced expression of GLUT 2 and glucokinase, resulting in impaired glucose tolerance. However, no effect on beta-cell mass and islet number was noted in mutant mice as compared with controls (4) . These data suggest that IGF-IR is not 5 essential for beta-cell growth and development, but participates in the mechanisms of glucose-stimulated insulin secretion of pancreatic beta cells.
Although still controversial, it appears that pancreatic beta cells arise from two main sources. New islets can be formed via budding from the pancreatic ductal epithelium (neogenesis) or through the proliferation of existing islets (6, 7) . Whereas neogenesis occurs during fetal development (8) and the regeneration of adult pancreas (9) , pancreatic beta-cell proliferation has been observed in the late fetal stages and also in normal adult pancreatic islet cells (6, 8) . Of the signals involved in triggering beta-cell mitogenesis, IGF-I is one of the best characterized. However, IGF-I induced beta-cell proliferation appears to depend on glucose, which alone is classic beta-cell mitogen (10) (11) (12) . Thus, glucose at low concentrations (5mM) activates p42/p44 MAPK and p70S 6 K by differential mechanisms in insulinoma cells; whereas glucose stimulates p42/p44 MAPK in a Ca 2+ -dependent manner, p70S 6 K activation was achieved in an ATP-dependent manner (13) . At high concentrations (16.5 mM), glucose induced insulin secretion in islets and lines of insulinomas but this effect required the expression of the transcriptional factor IPF-1/PDX-1. In fact, mutation of the Pdx-1 transactivation domain impaired insulin secretion in response to 16.7 mM glucose in INS-1 beta-cells. Interestingly, the expression of PDX-1 in INS-1 beta-cells is four-fold higher than in isolated islets; consequently, insulin secretion by these insulinoma-derived beta cells is highly responsive to glucose. However, it is uncertain whether the effect of glucose on insulinoma proliferation might reflect an underlying defect in insulin secretion. To address this important issue, we have generated fetal pancreatic beta cells without the insulin receptor. These cell lines have allowed us to examine the role of insulin in beta-cell proliferation and conversely, to analyze the glucose signaling component of beta-cell mitogenesis in the absence of insulin receptor signaling.
Materials and methods

Materials
Fetal calf serum and culture media were obtained from Gibco Inc. (Gaithersbury, MD (#A5441) and atractyloside (#6882) were from Sigma. PD98059 (#13000) and Rapamycin (#53210) were from Calbiochem (La Jolla, CA).
Generation of immortalized β-IRLoxP and β-IR -/-beta cell lines
Fetal pancreata were harvested from IRLoxP mice at late gestation and digested with collagenase. Animals were handled in accordance with approved institutional procedures.
Subsequently, 50-100 beta islets per pancreas were hand-picked under a dissection microscope and plated as previously described (14) . At this stage of development, beta islets showed a differentiated phenotype yet maintained their proliferative capacity. Viral
Bosc-23 packaging cells were transfected by the calcium phosphate method with 3 µg/6
cm-dish of the puromycin-resistance retroviral vector pBabe containing attenuated SV40
Large T antigen. Then, the beta islets growing on a fibroblasts monolayer were infected with the retroviral particles. After 72 h, islets were carefully hand-picked from the monolayer using a dissection microscope and replated. Beta cells obtained from these islets were expanded for one week in DMEM with 20%FBS in order to eliminate contaminating fibroblasts and subsequently, subjected to puromycin selection (1 µg/ml) for one week. In addition, IRLoxP beta cells were subcloned twice to select them from other islet-derived cell types. Immortalized beta cells were established and grown in 10% FBS-DMEM. These cells maintained their cell-cell contact inhibition. For in vitro deletion of the insulin receptor, beta cells harboring a floxed allele of the insulin receptor (IRLoxP) were first placed at a subconfluent density. After 24 h, cells were infected with adenovirus encoding cre recombinase at a titer of 10 9 plaque-forming units. After 1 h, the viral supernatant was replaced with culture medium. Individual colonies were selected for IR recombination by PCR. Then, although these IR-deficient cells grew more slowly, they were cloned twice and re-subjected to viral infection to assure complete deletion of the insulin receptor.
Cell signaling
For cell signaling experiments, both lines of beta cells, beta-IRLoxP and beta-IR-/-, were serum-starved for 16-20 hours and subsequently stimulated with insulin or glucose for 5 minutes and 15 minutes, respectively. Afterwards, cells were washed twice with PBS and lysed for total protein extraction according to standard procedure (14) . This protocol was used in Figure 1 .
Immunoflourescence and confocal imaging
Cells were grown on glass coverslips until 80% confluence was reached. Then, cells Immunoflourescence was examined in an MRC-1024 (Bio-Rad, Hempstead, UK) confocal microscope adapted to an inverted Nikon Eclipse TE 300 microscope.
Reverse Transcription (RT)-PCR
Immortalized beta cells, primary islets and NIH3T3 fibroblasts (80-90% confluence)
were serum-starved for 16-20 h and stimulated with glucose at 3 or 25 mM for 24 hours.
Afterwards, cells were washed twice with PBS and lysed for total RNA extraction according to standard procedure (15) . Total RNA was reverse transcribed into cDNA, as previously published (16) .
Immunoprecipitations and Western blot analysis
Quiescent cells (20 h serum-starved) were treated with several doses of insulin and glucose and lysed as previously described (17) . After protein content determination, western blot analysis was performed (17) .
PI 3-kinase activity
PI 3-kinase activity was measured in the anti-Tyr(P) immunoprecipitates by in vitro phosphorylation of phosphatidylinositol as previously described (17) .
Cell proliferation
Cells were plated in 6 cm-multiwell plates and cultured in 10% FBS-DMEM until 40-50 % of confluence was reached. Then, cells were serum-starved for a minimum of 4 hours 
Protein determination
Protein determination was by the Bradford dye method (18), using the Bio-Rad reagent and BSA as the standard.
RNA extraction and Northern blot analysis
Primary beta cells and MIN-6 cells were grown until confluence. Then, cells were serum-starved for 20 h and further incubated for 24 h in the presence of glucose (5 and 25 mM). Then, total RNA was isolated as described (15) and submitted to Northern blot analysis (16) .
Results
Characterization of immortalized beta cells
Our first goal was to characterize the phenotype of these new cell lines. Thus, we performed immunoflourescence with antibodies against insulin (a β-cell-specific marker) and vimentin (a marker for cells of mesenchymal origin). β-IRLoxP beta cells stained positive for insulin, indicating that these cells maintained beta cell phenotypic features.
Conversely, the beta cell lines were negative for vimentin ( To assess the distinct contributions of glucose vs. insulin signaling, we generated ß-cells lacking the insulin receptor (Fig. 1D ). The deletion of the insulin receptor was further confirmed by analysis of insulin receptor phosphorylation. We observed an increase in IR β-chain tyrosine phosphorylation in a dose-dependent manner in β-IRLoxP beta cells. In contrast, insulin stimulation produced no detectable IR phosphorylation in Iß-IR-/-beta cells, as expected ( Fig 1D) .
Downstream PI 3-kinase-dependent and -independent signaling in β-IRLoxP and ß-IR-/-beta cells
The insulin signaling cascade begins when the activated IR phosphorylates tyrosine residues of insulin receptor substrate (IRS) docking proteins (19, 20) . Then, phosphorylated IRSs bind proteins such as the p85 regulatory subunit of PI 3-kinase.
Treatment of the β-IRLoxP beta-cell line with insulin or IGF-I for 2 h stimulated Tyr(P)-associated PI 3-kinase activity. However, exposure to various concentrations of glucose for 24 h had no effect on phophotyrosine-associated PI 3 kinase activity ( 3B , left panel). In addition, wortmannin did not produce any significant direct effect on mTOR phosphorylation as densitometrically quantified (Fig. 3B, right panel) . Moreover,
we noted a differential effect of PD98059 on glucose-induced phosphorylation of p70S 6 K sites; whereas this inhibitor exerted no effect on Thr421/Ser424 phosphorylation sites, phosphorylation of Thr389 was completely blocked, as statistically quantified by densitometry ( Fig 4B) . Finally, treatment with rapamycin totally abolished the glucosemediated phosphorylation of mTOR Ser 2448 and p70S 6 K Thr421/Ser424 and Thr389 in β-IR-/-beta cells (Figs. 3B and 4B, respectively). In the presence of rapamycin plus PD98059, the effect on p70S 6 K Thr421/Ser424 phosphorylation site was even below its basal level (Fig. 4B) . These results suggest that glucose may activate a MEK-1/mTOR/p70S 6 K signaling pathway in insulin-receptor deficient beta cell lines.
Mitogenic effects of insulin or glucose in immortalized beta cell lines
Next, we studied the effects of insulin and glucose on ß-cell proliferation as determined by PCNA protein expression and ß-cell number. We observed that, during a 24-h time-course, 10 nM insulin or 5 mM glucose increased PCNA protein expression in β-IRLoxP and βIR-/-cells, respectively ( However, the combined addition of PD98059 and wortmannin completely blocked insulininduced β-cell mitogenesis (Fig. 5A ). These results suggest that activation of both IRSdependent PI 3 kinase and MEK-1 pathways is required for beta-cell mitogenesis in response to insulin. Finally, 20 nM rapamycin abolished insulin-mediated mitogenesis in β-IRLoxP beta cells (Fig. 5A) . These results are consistent with those seen above in Figs   3A and 4A, suggesting that signals from the PI 3 kinase and MEK-1 pathways converge on the mTOR/p70S 6 K pathway to mediate fetal beta-cell proliferation in response to insulin.
By contrast, in IR-deficient beta cells, the sole addition of PD98059 totally blunted glucose-stimulated mitogenesis. However, wortmannin had no effect on proliferation in this cell line (Fig. 5B ) which was expected given that glucose did not activate PI 3 kinase signaling in IR-deficient cells. As observed in the IR-expressing beta cell line, rapamycin produced a total block of beta-cell mitogenesis in response to glucose, paralleling its inhibitory effect on mTOR/p70S 6 K signaling. Finally, combined addition of PD98059 and rapamycin also inhibited mitogenesis of ß-IR-/-beta cells (Fig. 5B) . These data are also consistent with data of Figs. 3B and 4B, suggesting that the MEK-1/mTOR/p70S 6 K pathway mediates fetal beta-cell proliferation in response to glucose. These results also agree with recent evidence suggesting that p70S 6 K, but not Akt, directly leads to phosphorylation of mTOR on serine 2448 in cells (27, 28) . No rapamycininsensitive glucose-induced p70S 6 K phosphorylation sites were found in beta cells as previously described (25). Thus, rapamycin impaired beta-cell mitogenesis in response to glucose. Taken together, these data indicate that glucose-induced activation of MEK-1/mTOR/p70S 6 K Thr389 signaling pathway is necessary and sufficient to induce mitogenesis in beta cells lacking insulin receptors.
In conclusion, our results demonstrate that the insulin receptor, independent of glucose signaling, plays an essential role in the regulation of mitogenesis in fetal pancreatic beta cell lines, requiring both the PI 3 kinase and MEK-1 pathways to fully activate mTOR/p70S 6 K. Moreover, our cell lines reveal that glucose induces beta-cell mitogenesis in the absence of the insulin receptor by activating signals which are not dependent on PI 3 kinase, revealing that phosphorylation at Thr389 of p70S 6 K is necessary and sufficient to mediate mitogenesis in insulin-receptor deficient fetal beta cell lines (Fig.6 ). 
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